INTERNATIONAL PATENT: SYMBIO PHARMACEUTICALS LIMITED, THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES FILES APPLICATION FOR "BRINCIDOFOVIR FOR TREATMENT OF MULTIPLE SCLEROSIS"

GENEVA, April 8 -- SYMBIO PHARMACEUTICALS LIMITED (4-1-28 Toranomon, Minato-kuTokyo, 105-0001), THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (31 Center Drive, Suite 8a52Bethesda, MD 20892) filed a patent application (PCT/US2024/049002) for "BRINCIDOFOVIR FOR TREATMENT OF MULTIPLE SCLEROSIS" on Sep 27, 2024. With publication no. WO/2025/072782, the details related to the patent application was published on Apr 03, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): JACOBSON, Stephen (10 Center DriveBethesda, MD 20892), YOSHIDA, Fuminori (4...